A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous [1]

C. Wojcik, I. Mlynarczuk, G. Hoser, J. Kawiak, T. Stoklosa, J. Golab, S. Wilk

Research output: Contribution to journalLetter

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)1827-1828
Number of pages2
JournalBlood
Volume94
Issue number5
StatePublished - Sep 1 1999

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Wojcik, C., Mlynarczuk, I., Hoser, G., Kawiak, J., Stoklosa, T., Golab, J., & Wilk, S. (1999). A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous [1]. Blood, 94(5), 1827-1828.